Earl Douglas - Applied Molecular Exec Counsel
| AMTIDelisted Stock | USD 0.26 0.00 0.00% |
Insider
Earl Douglas is Exec Counsel of Applied Molecular TransportInc
| Age | 60 |
| Phone | 650 392 0420 |
| Web | https://www.appliedmt.com |
Applied Molecular Management Efficiency
The company has return on total asset (ROA) of (0.5125) % which means that it has lost $0.5125 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.5805) %, meaning that it created substantial loss on money invested by shareholders. Applied Molecular's management efficiency ratios could be used to measure how well Applied Molecular manages its routine affairs as well as how well it operates its assets and liabilities.The company currently holds 36.12 M in liabilities with Debt to Equity (D/E) ratio of 0.38, which is about average as compared to similar companies. Applied Molecular has a current ratio of 6.13, suggesting that it is liquid enough and is able to pay its financial obligations when due. Debt can assist Applied Molecular until it has trouble settling it off, either with new capital or with free cash flow. So, Applied Molecular's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Applied Molecular sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Applied to invest in growth at high rates of return. When we think about Applied Molecular's use of debt, we should always consider it together with cash and equity.
Similar Executives
| Showing other executives | INSIDER Age | ||
| Alan MacKenzie | Bio Path Holdings | N/A | |
| Joseph CPA | Inhibikase TherapeuticsInc | 62 | |
| MBA MD | Monopar Therapeutics | 38 | |
| George Eldridge | Aerovate Therapeutics | 61 | |
| Justin Trojanowski | Tempest Therapeutics | 36 | |
| Benjamin Dake | Aerovate Therapeutics | 48 | |
| Sanjay Chanda | AN2 Therapeutics | 59 | |
| Qinghai Zhao | Adagene | 63 | |
| Man MBA | Adagene | 47 | |
| Kanya MD | Senti Biosciences | 51 | |
| Philip Lee | Senti Biosciences | 42 | |
| Crystal Mercado | Acrivon Therapeutics Common | N/A | |
| Anne Moon | Tempest Therapeutics | N/A | |
| MD MBA | Rezolute | N/A | |
| Andrew MBA | Monopar Therapeutics | 51 | |
| BSc FRCPC | Inhibikase TherapeuticsInc | N/A | |
| James Collins | Senti Biosciences | 57 | |
| Anne McKay | Fennec Pharmaceuticals | 70 | |
| Peter MD | Acrivon Therapeutics Common | 61 | |
| MD FACP | AN2 Therapeutics | 76 | |
| Donna Dea | Aerovate Therapeutics | N/A | |
Management Performance
| Return On Equity | -1.58 | |||
| Return On Asset | -0.51 |
Applied Molecular Leadership Team
Elected by the shareholders, the Applied Molecular's board of directors comprises two types of representatives: Applied Molecular inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Applied. The board's role is to monitor Applied Molecular's management team and ensure that shareholders' interests are well served. Applied Molecular's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Applied Molecular's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Andrew Chang, Head Communications | ||
| Earl Douglas, Exec Counsel | ||
| Bittoo MD, Chief Officer | ||
| Graham Cooper, Ex Chairman | ||
| Shawn Cross, Pres COO | ||
| Tahir Mahmood, CEO CoFounder | ||
| Andy Whitney, VP Science | ||
| MBA MBA, Chief Officer | ||
| Randall Mrsny, CoFounder Director | ||
| Brandon Hants, Chief Officer |
Applied Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Applied Molecular a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -1.58 | |||
| Return On Asset | -0.51 | |||
| Current Valuation | (5.88 M) | |||
| Shares Outstanding | 41.85 M | |||
| Shares Owned By Insiders | 21.35 % | |||
| Shares Owned By Institutions | 37.20 % | |||
| Number Of Shares Shorted | 292.87 K | |||
| Price To Book | 0.70 X | |||
| Gross Profit | (42.08 M) | |||
| EBITDA | (127.22 M) |
Pair Trading with Applied Molecular
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Applied Molecular position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Applied Molecular will appreciate offsetting losses from the drop in the long position's value.Moving against Applied Stock
| 0.82 | PPERY | Bank Mandiri Persero | PairCorr |
| 0.78 | BKRKY | Bank Rakyat | PairCorr |
| 0.76 | IBM | International Business Financial Report 17th of July 2024 | PairCorr |
| 0.63 | PTBRY | Bank Negara Indonesia | PairCorr |
| 0.6 | BKRKF | PT Bank Rakyat | PairCorr |
The ability to find closely correlated positions to Applied Molecular could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Applied Molecular when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Applied Molecular - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Applied Molecular TransportInc to buy it.
The correlation of Applied Molecular is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Applied Molecular moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Applied Molecular moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Applied Molecular can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Other Consideration for investing in Applied Stock
If you are still planning to invest in Applied Molecular check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Applied Molecular's history and understand the potential risks before investing.
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |